BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. scores highest on Earnings (89) and lowest on Price (34). Its PosiPenta is 60.18 out of 100, better than most similar companies.
On the Penta Grid this week, BioMarin Pharmaceutical Inc. is Grid #144 of 837 in the Healthcare sector in United States, and Grid #601 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 60.18 | 34 | 89 | 66 | 51 | 60 |
| Globus Medical, Inc. | 65.65 | 58 | 70 | 73 | 76 | 52 |
| Align Technology, Inc. | 66.24 | 50 | 88 | 65 | 74 | 53 |
| Universal Health Services, Inc. | 67.45 | 75 | 60 | 72 | 58 | 72 |
| Molina Healthcare, Inc. | 60.26 | 24 | 88 | 85 | 47 | 57 |
| Elanco Animal Health Incorporated | 56.85 | 31 | 80 | 78 | 50 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 147.78 |
| P/B ratio | 1.67 |
EEarnings
| Trailing EPS | ₹35.04 |
| Forward EPS | ₹616.17 |
NNitro
| Price | 5179.01 |
| 52-week high | 6722.87 |
| 52-week low | 4665.66 |
| Fall from 52-week high | 23.0% |
TTorque
| Return on equity (ROE) | 1.18% |
| Debt-to-equity | 0.66 |
AAnchor
| Beta (price swings) | 0.21 |
| Market cap | ₹1,00,252 Cr |
| Insider holding | 0.34% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is BioMarin Pharmaceutical Inc.'s PosiPenta score?
BioMarin Pharmaceutical Inc.'s PosiPenta is 60.18 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does BioMarin Pharmaceutical Inc. stand on the Penta Grid?
On the Penta Grid this week, BioMarin Pharmaceutical Inc. is Grid #144 of 837 in the Healthcare sector in United States, and Grid #601 of 4,000 in United States.
Which PosiPenta pillar is strongest for BioMarin Pharmaceutical Inc.?
Earnings (growth), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for BioMarin Pharmaceutical Inc.?
Price (valuation), with a score of 34 out of 100: weaker than most similar companies.
Has BioMarin Pharmaceutical Inc.'s PosiPenta changed since last week?
Yes, it rose 16.26 points, from 43.92 to 60.18.
PositoAI is for research and education only and is not investment advice.